Anhui Anke Biotechnology (Group) Co (SZSE:300009) GF Value : ¥12.03 (As of Dec. 14, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co GF Value?

As of today (2024-12-14), Anhui Anke Biotechnology (Group) Co's share price is ¥9.07. Anhui Anke Biotechnology (Group) Co's GF Value is ¥12.03. Therefore, Anhui Anke Biotechnology (Group) Co's Price-to-GF-Value for today is 0.75. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Anhui Anke Biotechnology (Group) Co is Modestly Undervalued.

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

Anhui Anke Biotechnology (Group) Co (SZSE:300009) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Anhui Anke Biotechnology (Group) Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	9.07	/	12.03
	=	0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anhui Anke Biotechnology (Group) Co GF Value Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Anke Biotechnology (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088

Website

http://www.ankebio.com

Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.

Executives

Zhou Yuan Yuan	Directors, executives
Wang Yong	Supervisors
Yao Jian Ping	Executives
Wang Rong Hai	Directors, executives
Song She Wu	Directors, executives
Fu Yong Biao	Directors, executives
Jiang Jun Pei	Supervisors
Zhao Hui	Directors, executives
Xu Zhen Shan	Director
Lu Guang Xin	Executives
Yan Xin Wen	Executives
Lu Chun Yan	Executives
Wu Rui	Director
Fan Qing Lin	Director
Wang Yong Bin	Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines